Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style. - Wikidata - wikimedia - TriplyDB

Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style.

Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style.

http://www.wikidata.org/entity/Q33514578

about

Dendrimer advances for the central nervous system delivery of therapeutics In vitro and in vivo antitumor activity of a novel pH-activated polymeric drug delivery system for doxorubicin Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics Poly(ethylene oxide)-block-polyphosphoester-graft-paclitaxel conjugates with acid-labile linkages as a pH-sensitive and functional nanoscopic platform for paclitaxel delivery Cytotoxicity and biodistribution studies on PEGylated EDA and PEG cored PAMAM dendrimers.Charge-reversal polyamidoamine dendrimer for cascade nuclear drug delivery.Theranostic tumor homing nanocarriers for the treatment of lung cancer Effect of the Route of Administration and PEGylation of Poly(amidoamine) Dendrimers on Their Systemic and Lung Cellular Biodistribution.Comparative studies of polyethylenimine-doxorubicin conjugates with pH-sensitive and pH-insensitive linkers.Stimuli Sensitive Amphiphilic Dendrimers.Multifunctional drug nanocarriers formed by cRGD-conjugated βCD-PAMAM-PEG for targeted cancer therapy Dendrimer nanocarriers for transport modulation across models of the pulmonary epithelium.Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab Development of individualized anti-metastasis strategies by engineering nanomedicines Synthesis and in vitro evaluation of pH-sensitive PEG-I-dC16 block polymer micelles for anticancer drug delivery.A pH-responsive prodrug delivery system of 10-HCPT for controlled release and tumor targeting The effect of the acid-sensitivity of 4-(N)-stearoyl gemcitabine-loaded micelles on drug resistance caused by RRM1 overexpression.Peptide mediated active targeting and intelligent particle size reduction-mediated enhanced penetrating of fabricated nanoparticles for triple-negative breast cancer treatment.Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry.Trastuzumab-grafted PAMAM dendrimers for the selective delivery of anticancer drugs to HER2-positive breast cancer.Zwitterionic chitosan-polyamidoamine dendrimer complex nanoparticles as a pH-sensitive drug carrier.Deposition of doxorubicin in rats following administration of three newly synthesized doxorubicin conjugates.Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.Dendrimers and miktoarm polymers based multivalent nanocarriers for efficient and targeted drug delivery.Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms.Microfabricated particulate drug-delivery systems.Acid-degradable polymers for drug delivery: a decade of innovation.Reversibly crosslinked nanocarriers for on-demand drug delivery in cancer treatment.pH-sensitive drug-delivery systems for tumor targeting.Preclinical studies of dendrimer prodrugs.Partially PEGylated PAMAM dendrimers as solubility enhancers of Silybin.Synthesis of a novel PEGDGA-coated hPAMAM complex as an efficient and biocompatible gene delivery vector: an in vitro and in vivo study.Polypeptide-based Micelles for Delivery of Irinotecan: Physicochemical and In vivo Characterization.Molecularly precise dendrimer-drug conjugates with tunable drug release for cancer therapy.Hydrophobic cavity formed by oligopeptide for doxorubicin delivery based on dendritic poly(L-lysine).EphA2 targeting pegylated nanocarrier drug delivery system for treatment of lung cancer.Synergistic antitumor effects of doxorubicin-loaded carboxymethyl cellulose nanoparticle in combination with endostar for effective treatment of non-small-cell lung cancer.Peptide dendrimer-Doxorubicin conjugate-based nanoparticles as an enzyme-responsive drug delivery system for cancer therapy.Development of biodegradable polymeric implants of RGD-modified PEG-PAMAM-DOX conjugates for long-term intratumoral release.

P2860

Q26828423-01B06A62-BD1F-4BB2-802E-41C15BABD0FD Q28483980-40FD737C-5965-41F2-AF1A-68EFF30106E7 Q30421664-EA555393-D755-48ED-8774-070C7A619C6F Q30664584-A6F28870-FB1F-4B56-8F81-DBD6BA152516 Q31122095-39465F6A-AF47-45E9-A71B-B6EFD5CCD215 Q33734954-42762D19-1304-4C59-A19B-2D3FD46926CB Q33769951-E170E437-DE86-4A46-A850-B43397DD1D36 Q33792946-83178A0A-0AE6-4BE8-908B-DDEEB797055B Q34445374-4988A615-D1EE-41E0-9CBD-4CFFD836275F Q34987929-B7BE1C07-3769-45F3-8168-DF975188E59E Q35108257-5134F69D-803A-41BF-BAC5-673984D431EC Q35150539-EDF65C4B-7D32-4012-BEFB-4EB66C2E7793 Q35234716-0416C1FE-E935-4032-8AEA-58F5FB19BC06 Q35967474-4881E845-35DB-4337-AF8B-1233D37F535D Q35971215-613898FE-2E39-4878-9D18-A31C2088E4F0 Q36327549-00E3314B-22D1-439D-8660-684C36103DF2 Q36553206-EF8EDB92-916E-47A1-B753-F46951770E8D Q36562350-4AAC5286-7D01-464F-89F4-81A6A267DB3C Q36690711-9C9D5B75-242B-461E-A18A-D67499F372EE Q36774169-3BB942B1-D15D-4C3D-AE83-A30C05DB73F2 Q36823809-6ECB34A2-27CC-431C-9F5D-3F385B00E829 Q37408047-04345661-F9DA-4EC9-9DF9-B3DBE53E40A5 Q37624646-5D0570AC-E5A9-4816-B106-DF798FFE9E19 Q37823446-89673A71-7792-491D-965A-6C18D6F63FD0 Q37886750-F3DB1347-D580-4788-8707-A69D3B61DA1C Q37938830-5555256E-7B8F-45EA-A790-544FF365B20C Q37955127-F5F1CA53-55F0-4A8F-9ECD-268ABC578567 Q38074172-5AFDF20C-A998-475D-8A77-E1F55A5F5175 Q38074441-E2583DCD-C7A5-4245-B0ED-FCA72567A4D9 Q38168593-98E3F896-5130-45D2-BECC-C5F9146A4C60 Q38509638-29C27180-0666-4DA4-B1B4-C2681CB217BF Q38736230-4E8D6EE0-5F73-46A2-8784-8346F687CDB4 Q38753654-410EA70B-9072-4A19-AA3E-0EBDA3381310 Q38932548-AB3ECFBA-2B49-41C6-87CA-AFB90FDD03D3 Q38962983-EC40E203-7EED-472C-9918-9D170C05C03F Q38973975-DBF20A05-FF65-46D2-85BF-FE09B147DDF6 Q38990966-941D8389-7735-4F80-B316-32A6C619E967 Q38993179-A12183D8-9F1E-4515-8950-0F83D645CEA6 Q39007103-ED7A83CC-DC1F-4803-918C-D076FC6D7DE3 Q39011604-1C137782-ED09-44A7-8557-E08C24B7476A

P2860

Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style.

http://www.wikidata.org/entity/Q33514578

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Partly PEGylated polyamidoamin ...... ee and drug conjugation style.

@ast

Partly PEGylated polyamidoamin ...... ee and drug conjugation style.

@en

Partly PEGylated polyamidoamin ...... ee and drug conjugation style.

@nl

type

label

Partly PEGylated polyamidoamin ...... ee and drug conjugation style.

@ast

Partly PEGylated polyamidoamin ...... ee and drug conjugation style.

@en

Partly PEGylated polyamidoamin ...... ee and drug conjugation style.

@nl

prefLabel

Partly PEGylated polyamidoamin ...... ee and drug conjugation style.

@ast

Partly PEGylated polyamidoamin ...... ee and drug conjugation style.

@en

Partly PEGylated polyamidoamin ...... ee and drug conjugation style.

@nl

P1433

Q33514578-4DEB12A4-F808-4316-B49F-03C19F6FAD58

P1476

Q33514578-4BCDABBB-8A0D-4A6D-A75C-4315199B9649

P2093

Q33514578-024CB0EE-54A7-4998-87AC-5E74B502226E

Q33514578-18440147-19E8-47BC-8E9C-57F263C07BE1

Q33514578-23C76953-C50D-477B-A3DC-95F63CF63225

Q33514578-240E8B59-74CB-46B6-80E2-C7F1975292D5

Q33514578-5A76011D-58C6-4E6F-901E-69D5E153A53C

Q33514578-89CFD9CF-E935-4278-BBC0-01FA644205AD

Q33514578-D9139926-7CFA-44D0-B568-3E9B66D9145A

P304

Q33514578-9358A939-3A9B-4F49-8755-181BACF87AC6

P31

Q33514578-A592EEE3-06BB-4D85-ABDA-2BFABADC482B

P356

Q33514578-594DBE85-EC11-4C5E-99F9-796309351E96

P433

Q33514578-D2CFC2C0-9369-45AF-B393-22CC3689E906

P478

Q33514578-52127799-5411-45D3-9161-0FF852FE333E

P577

Q33514578-C9AD226D-41E1-4A1A-ACBA-E66BEA374887

P698

Q33514578-C2C3EF72-4B46-4C80-81B9-97EE867557A3

P356

J.BIOMATERIALS.2009.10.044

P1433

P1476

Partly PEGylated polyamidoamin ...... ee and drug conjugation style.

@en

P2093

Guotao Tang

http://www.w3.org/2001/XMLSchema#string

Jiayuan Lin

http://www.w3.org/2001/XMLSchema#string

Lili Qian

http://www.w3.org/2001/XMLSchema#string

Minghuang Hong

http://www.w3.org/2001/XMLSchema#string

Saijie Zhu

http://www.w3.org/2001/XMLSchema#string

Yanyan Jiang

http://www.w3.org/2001/XMLSchema#string

Yuanying Pei

http://www.w3.org/2001/XMLSchema#string

P304

1360-1371

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOMATERIALS.2009.10.044

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2009-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19883938

http://www.w3.org/2001/XMLSchema#string